MONTREAL, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“ Theratechnologies ” or the “ Company ”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, announced...
MONTREAL, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“ Theratechnologies ” or the “ Company ”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, announced...
MONTREAL, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“ Theratechnologies ” or the “ Company ”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, is pleased...
Today announced the availability of EGRIFTA WR™ (tesamorelin) for injection for the reduction of excess ...
EGRIFTA WR™ offers convenience of weekly reconstitution and reduced daily injection volume, compared to EGRIFTA SV ® Specialty pharmacies are now ordering EGRIFTA WR™ to fill prescriptions...
Your vote is important regardless of the number of Shares you own. Board unanimously recommends shareholders vote “FOR” the Arrangement. Shareholders are encouraged to review the circular carefully...
Shareholders stand to receive a significant and attractive cash premium, as the purchase price of US$3.01, with a contingent value right for potential additional aggregate payments of up to US$1.19 per...
Theratechnologies: Fiscal Q2 Earnings Snapshot